
Vegacef S 250mg/125mg Injection
Marketer
Adley Formulations
Salt Composition
Ceftriaxone (250mg) + Sulbactam (125mg)
Overview Vegacef S 250mg/125mg Injection
Cefaclor and Sulbactam injection (250mg/125mg), marketed as Vegacef S, is a dual-action antibiotic. This medication combats a range of bacterial infections by hindering microbial proliferation. Administration must be overseen by a qualified medical practitioner. Consistent adherence to the prescribed dosage schedule is crucial; completing the entire course is vital, even with symptom improvement. Premature cessation may compromise its effectiveness. Potential side effects include, but are not limited to, nausea, vomiting, diarrhea, and dyspepsia. Any worsening of these effects requires immediate medical attention. Allergic responses (e.g., skin rashes, itching, swelling, respiratory distress) necessitate prompt emergency care. Inform your doctor about all current medications before initiating treatment. Pregnant or lactating individuals must consult their physician. Alcohol consumption should be avoided due to the risk of increased drowsiness. While generally not impairing driving ability, refrain from driving if experiencing drowsiness or dizziness. Adequate rest, a nutritious diet, and sufficient hydration contribute to faster recovery. Your physician may order tests to monitor the medication's efficacy.
Primary Ingredients of Vegacef S 250mg/125mg Injection
There is no text provided to rephrase.
Uses of Vegacef S 250mg/125mg Injection
Infections caused by bacteria
Major Benefits of Vegacef S 250mg/125mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Vegacef S 250mg/125mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Vegacef S 250mg/125mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Vegacef S 250mg/125mg Injection works:
Ceftriaxone and sulbactam, the components of Vegacef S 250mg/125mg Injection, act synergistically to combat bacterial infections. Ceftriaxone, a cephalosporin antibiotic, disrupts bacterial cell wall synthesis, hindering their ability to survive. Sulbactam, a beta-lactamase inhibitor, counters bacterial resistance mechanisms, thereby bolstering Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Ingestion of alcohol alongside Vegacef S 250mg/125mg Injection presents no known adverse reactions.
PregnancySAFE IF PRESCRIBED
Cefovecin sodium 250mg/125mg injection is typically deemed safe for use in pregnancy. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; nonetheless, data from human trials are scarce.
Breast feedingCAUTION
Administering Vegacef S 250mg/125mg Injection to breastfeeding mothers requires careful consideration. Discontinue breastfeeding throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administration of Vegacef S 250mg/125mg Injection can induce drowsiness, visual disturbances, and dizziness. Refrain from operating vehicles should these effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Vegacef S 250mg/125mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
The use of Vegacef S 250mg/125mg Injection requires careful consideration in individuals with significant hepatic impairment; dosage modification may be necessary. Physician consultation is advised. Dosage alteration for Vegacef S 250mg/125mg Injection is not suggested for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Vegacef S 250mg/125mg Injection :
Omit a Vegacef S 250mg/125mg Injection dose? Seek medical advice.
Facts to Know About Vegacef S 250mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
